Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Cameron Hurst
ISHARES DOW JONES US MEDICAL DEV.(ETF)IHIPAST TOP PICKApr 10, 2019
(A Top Pick Apr 11/18, Up 25%) It is high quality with a 1.0 beta. He would stick with it as the fundamental still hold true -- aging population, diabetes, etc. There are 29 million US adults with Type 2 diabetes and another 84 million are pre-diabetic -- almost 1 in 3 adults.
Cameron HurstOwned
$230.15
Stock price when the opinion was issued
$49.28
As of Jun 18, 2026. Market Open.
E.T.F.'s
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
BUY
Allan Tong’s Discover Picks IHI's MER is actually higher (at 0.39%) than the yield it pays (0.3%). Like the other names here, IHI trades at a low beta, 0.86 to be precise. So, if you're not buying this for income, what's the growth? Let's look at IHI's largest holdings. TMO offers diversity among lab testing, lab equipment and diagnostics and typically trades at a premium multiple. TMO was a hit in the Covid-testing days, but that stereotype has stuck with them. The company reported a strong quarter a month ago, but that didn't move the needle. TMO shares have been choppy but rangebound all year, but if Wall Street gets gospel on TMO, share should pop. The price target is 20% higher at $674. Read 3 Best U.S. Healthcare ETFs for our full analysis.
E.T.F.'s
BUY
BUY
Not overly bullish on healthcare as a whole, as its growth may be less attractive. Likes medical devices, with a built-in backlog due to Covid. He owns SYK. There should be a significant pickup in procedures over the next 2 years. SYK has strong earnings growth, near a 1-year high. Also look at IHI, the medical devices ETF, packed with companies leading the healthcare sector.
E.T.F.'s
BUY
It specializes in medical devices and equipment. He has held this over a year and a half. He likes the diversification it offers. He is not sure which of the holdings are involved in manufacturing defibrillators.
John HoodOwned
E.T.F.'s
TOP PICK
TOP PICK
A perennial favorite for him. Worldwide hospital spending, global spending and Type II diabetes on the rise all make this a good holding. It is fairly high beta, so if the market falls this will fall too. Yield 0.31%
Cameron HurstOwned
E.T.F.'s
TOP PICK
The only area of healthcare he remains invested in. The demographics are creating tailwinds. An aging population and growing obesity is good for this. Good cash flow holdings and good diversification. Yield 0.32%
Cameron HurstOwned
E.T.F.'s
PAST TOP PICK
(A Top Pick Jul 11/18, Up 19%) A great example of demographic and diabetes trends that has created huge growth in demand. A sad, but profitable story. Not a defensive stock and has beta with the market.
Cameron HurstOwned
E.T.F.'s
PAST TOP PICK
(A Top Pick Jun 08/18, Up 11%) He continues to love holding this. Worldwide hospital spending continues to increase.
Cameron HurstOwned
E.T.F.'s
